This double-blind, randomized, placebo-controlled trial examined the effects of hyperbaric oxygen therapy (HBOT) on mitochondrial function and physical performance in 37 healthy middle-aged master athletes. Participants underwent 40 sessions of either HBOT (2 absolute atmospheres (ATA), breathing 100% oxygen for 1 hour) or a sham treatment (1.02 ATA, breathing air
